Try our Advanced Search for more refined results
Intellectual Property
-
April 10, 2026
DLA Piper Partner Rejects Pregnant Atty's Account Of Firing
The DLA Piper partner who fired a pregnant associate said she did so lawfully, telling a Manhattan federal jury her former employee was "in over her head" and disputing that the associate raised pregnancy bias concerns on a termination call.
-
April 10, 2026
Prince's Estate, 'Purple Rain' Co-Star Settle TM Suit
The estate of the pop singer Prince has reached a settlement with "Purple Rain" co-star Patty Apollonia Kotero to resolve a suit brought by Kotero over the trademark for "Apollonia."
-
April 09, 2026
Fed. Circ. Chief Feels 'Bright-Line Rule Coming' For IP Marking
As a Federal Circuit panel reprimanded embattled attorney William Ramey on Thursday for the "disrespect" shown in his failed 3D glasses patent litigation against Volkswagen, the Federal Circuit's chief judge suggested precedent may be needed to define the role of marking in admissionless settlements.
-
April 09, 2026
11th Circ. Affirms Dish Network's Copyright Win, $600K Award
The Eleventh Circuit Thursday refused to disturb a $600,000 copyright win for Dish Network in long-running litigation over Arabic pay-TV programming distribution, ruling that the lower court was correct in finding that Dish's copyrights were infringed.
-
April 09, 2026
BuzzBallz Rival Says 'Joke' Domain Grab Not Funny Or Legal
A claim by cocktail company BuzzBallz that its purchase of an upcoming rival's web domains was a "joke" is a shallow attempt to avoid responsibility for its anticompetitive cybersquatting actions, beverage company Patco Brands argued while urging a California federal court to deny BuzzBallz's motion for summary judgment.
-
April 09, 2026
Patent Review Upheaval Spurs Uncertainty Concerns
The U.S. Patent and Trademark Office's recent overhaul of patent review practices drew strong reactions at a conference Thursday, with attorneys lamenting increased uncertainty and a former agency director expressing both support for the moves and concern about policy "whipsawing" between administrations.
-
April 09, 2026
Albright Won't Toss BMW Suit Over German Patent Cases
A Texas federal judge said he wouldn't dismiss a suit brought by carmaker BMW AG that was intended to block two patent litigations from moving forward in German court, despite those cases having been withdrawn.
-
April 09, 2026
9th Circ. Upholds NCAA Eligibility Limit, Ends Player's Season
The Ninth Circuit has ended a University of Nevada baseball player's sixth season of competition, reversing a district court order that allowed him to start the season and upholding the NCAA's five-year eligibility limit.
-
April 09, 2026
Springsteen Merch Co. Files TM Suit Before NJ Concert
Merch Traffic LLC, the exclusive merchandiser for Bruce Springsteen and the E Street Band, filed suit in New Jersey federal court Thursday claiming that dozens of unidentified sellers plan to flood the Prudential Center with counterfeit Springsteen gear during the band's upcoming Newark concert.
-
April 09, 2026
Trade Secrets Suit Is A 'Far-Flung Conspiracy,' Law Firm Says
A Georgia law firm wants a Nevada federal court to throw out a lawsuit accusing it of stealing trade secrets from litigation lead generator Archetype Capital Partners, calling the whole case "a far-flung conspiracy."
-
April 09, 2026
Welch's Maker Tells ITC Rival Infringing 2 Fruit Snack Patents
The manufacturer of Welch's Fruit Snacks brought its fight against what it claims are patent-infringing yogurt-covered snacks produced by rival Cibo Vita to the U.S. International Trade Commission, the ITC said Thursday.
-
April 09, 2026
Doctor Who Sued Biotech Co. Over Arrest Wins $58M Verdict
A Georgia jury has handed a $58 million verdict to a retired Stanford University medical school professor who accused a Peach State biotech firm of conspiring to​​ have him criminally charged in a failed bid to avoid paying him millions in product design commissions.
-
April 09, 2026
Ex-Joe Gibbs Racing Director Pans 'Desperate' Discovery Bid
Joe Gibbs Racing LLC's efforts to subpoena cellphone providers for deleted text messages is a "desperate" ploy to dig up proof its trade secrets were stolen when there is no evidence to suggest that is the case, the NASCAR team's former competition director said.
-
April 09, 2026
Investor Says Chinese Firms Took $476M EV Venture Stake
A British Virgin Islands company accused a Chinese state-owned enterprise of exploiting COVID-19 travel bans to seize its 11% stake in an electric vehicle manufacturer, wiping out the investor's equity without compensation and stealing proprietary technology.
-
April 09, 2026
Church Wins Default Judgment Against Proud Boys In TM Suit
A Washington, D.C., African Methodist Episcopal church has won a default judgment and permanent injunction against a New York chapter of the extremist Proud Boys group barring the chapter from further infringement of the church's "Proud Boys" mark.
-
April 09, 2026
Nonprofit Insurer Wants To Seek AstraZeneca Claims Revival
EmblemHealth asked a Massachusetts federal judge to let it seek First Circuit intervention against a decision that cut in half its proposed class action accusing AstraZeneca unit Alexion of using sham patents to protect blood disorder treatment Soliris from biosimilar rivals.
-
April 09, 2026
Albright Clears Computer Cooling Systems Co. In Patent Fight
Green Revolution Cooling Inc. was handed a quick win by U.S. District Judge Alan Albright in a suit accusing it of infringing a competitor's patent on products used to cool down electronics at data centers, just before a trial was set to start next month.
-
April 09, 2026
Abiomed Can't Escape Blood Pump Patent Case
A Massachusetts federal judge has refused to let a Johnson & Johnson MedTech subsidiary dodge claims that it infringed a blood pump patent, the latest event in a wider legal battle launched against it by a unit of Swedish medical device company Getinge AB.
-
April 09, 2026
Ex-Pharmacy Director Denies Using Trade Secrets At New Job
A former director at a specialty infusion therapy pharmacy urged a New Jersey federal court to reject her former employer's bid to block her from working for a rival, arguing that her new job does not pose any threat of imminent harm to her former company.
-
April 09, 2026
Copyright Chief Decries 'Cataclysmic' High Court Cox Ruling
U.S. Copyright Office leader Shira Perlmutter expressed grave concern at a conference Thursday about the ramifications of the U.S. Supreme Court's recent decision shielding Cox Communications in a music piracy case, saying the "somewhat cataclysmic" ruling significantly restricted copyright infringement liability.
-
April 09, 2026
ITC Opens Investigation Into Imported Screen Protectors
The U.S. International Trade Commission on Thursday said it is opening an investigation into Belkin's claims that a rival is importing and selling screen protectors that infringe a trio of Belkin patents.
-
April 09, 2026
PNC Tells Justices $233M Patent Win Was Rightly Axed
PNC Bank told the U.S. Supreme Court to leave untouched a Federal Circuit ruling that nixed a set of $233 million patent infringement verdicts in suits brought by the United Services Automobile Association, saying USAA's patents were "plainly directed to an abstract idea" not eligible for patent protection.
-
April 09, 2026
Heim Payne Adds New TM Litigation & Appeals Group Leader
Houston-based Intellectual property boutique Heim Payne & Chorush LLP has brought on an attorney with decades of experience, including time as an examiner with the U.S. Patent and Trademark Office early in her legal career, to lead the firm's trademark litigation and appeals practice.
-
April 09, 2026
Ex-Assurant Workers Look To Toss RICO, Trade Secrets Suit
A group of former Assurant salesmen called the auto warranty underwriter's eighth attempt at bringing Racketeer Influenced and Corrupt Organizations and trade secrets claims a shotgun pleading, arguing in Georgia federal court that competition and criminal enterprise are not the same.
-
April 08, 2026
Fed. Circ. Questions Specificity Needed In Oxy IP Invalidation
A Federal Circuit panel expressed frustration with attorneys from both Purdue Pharma LP and generic-drug maker Accord Healthcare Inc. Wednesday as it tried to navigate whether the Delaware district court order invalidating Purdue's abuse-deterrence patent was explicit enough.
Expert Analysis
-
Learning From A Typical Section 1782 Discovery Case
A California federal judge's recent approval of a Section 1782 application, compelling a U.S.-based company to produce materials relevant to a German patent dispute, usefully illustrates the specific steps foreign litigants must undertake before wielding this powerful tool for obtaining evidence unavailable via discovery mechanisms abroad, say attorneys at Fish & Richardson.
-
How To Trademark A Guy In 8 Ways: An IP Strategy Against AI
Attempting a novel method of protection against artificial intelligence misuse of his voice and likeness, Matthew McConaughey's recent efforts to register eight trademarks for a series of audio and video clips of himself underscore the importance of extending existing legal frameworks beyond traditional applications, says Summer Todd at Patterson Intellectual Property.
-
Utilizing The ITC To Combat 'Gray Market' IP Infringement
As technological developments intensify trademark owners' need to respond swiftly to "gray market" sales of international goods imported into the U.S. without the trademark owner's consent, litigating at the U.S. International Trade Commission offers an underutilized enforcement option, say attorneys at MoFo.
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination
With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Upshot Of 'Skinny Label' Case May Go Beyond Pharma
The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.
-
Assessing Factors Behind Biosimilar Uptake And Competition
As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.
-
How 2 Tech Statutes Are Being Applied To Agentic AI
The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.
-
FTC Focus: Testing Joint Enforcement Over Loyalty Programs
The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.
-
NYC Bar Opinion Warns Attys On Use Of AI Recording Tools
Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.
-
Series
The Biz Court Digest: Dispatches From Utah's Newest Court
While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.
-
Checking In On Biologics-Related Patent Review Trends
Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.
-
4 Quick Emotional Resets For Lawyers With Conflict Fatigue
Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.
-
Patent Eligibility Faces Widening Gap Between USPTO, Courts
The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.